In this week’s edition of InnovationRx, we look at a patent fight over the world’s top-selling drug, breakthroughs from the American Association for Cancer Research, Verily’s Parkinson’s dataset, the ...

GSK plc GSK reported first-quarter 2025 core earnings of $1.13 per American depositary share (ADS), which beat the Zacks ...

As GSK weathers the storm of sinking vaccine sales and gears up for key launches in its specialty medicines sector, the ...

Amid sweeping budget cuts and layoffs, HHS Secretary Robert F. Kennedy Jr. is planning a $20 million ad campaign urging ...

Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.

Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...

Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...

Public health experts worried about the future of vaccination in the US have come together in an unprecedented new initiative ...

SOUTH SAN FRANCISCO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that it completed enrollment of its Phase 1 clinical trial evaluating its second-generation ...

It began quietly—missing drugs deliveries, empty shelves—but today, Uganda’s healthcare system is facing a full-blown crisis ...

Despite Nigeria’s robust pharmaceutical landscape, boasting over 150 registered manufacturers, challenges persist.

GSK on Wednesday said it was "well positioned" to absorb potential U.S. pharmaceutical tariffs, citing AI-driven cost cuts ...